UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000047145
Receipt number R000053778
Scientific Title Feasibility of monitoring depth of analgesia by ultrasound of pupillary dilated reflex diameter in response to nociceptive stimulation
Date of disclosure of the study information 2022/03/11
Last modified on 2022/03/11 00:32:01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Feasibility of monitoring depth of analgesia by ultrasound of pupillary dilated reflex diameter in response to nociceptive stimulation

Acronym

Feasibility of monitoring depth of analgesia by ultrasound of pupillary dilated reflex diameter in response to nociceptive stimulation

Scientific Title

Feasibility of monitoring depth of analgesia by ultrasound of pupillary dilated reflex diameter in response to nociceptive stimulation

Scientific Title:Acronym

Feasibility of monitoring depth of analgesia by ultrasound of pupillary dilated reflex diameter in response to nociceptive stimulation

Region

Japan


Condition

Condition

Adult healthy volunteers

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The pupillary dilated reflex in response to painful stimuli has attracted attention as an indicator of the depth of analgesia. However, frequent eye-opening maneuvers are associated with the risk of corneal damage and infection. This study aims to investigate the reproducibility of pupil measurement by ultrasonography as an alternative to electronic pupillometry, we will compare and investigate the change in pupil diameter due to pain stimulation using each measurement device.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Pupil dilation reflex change in response to noxious stimulation measured by infrared video pupillometry and ultrasonography.

Key secondary outcomes

NRS(Numerical Rating Scale) after noxious stimulation.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

60 years-old >=

Gender

Male and Female

Key inclusion criteria

Healthy adults.

Key exclusion criteria

Any ocular disease , neurological diseases , history of any type of ocular surgery or laser treatment and taking topical or systemic medications potentially affecting pupillary function.

Target sample size

15


Research contact person

Name of lead principal investigator

1st name Mao
Middle name
Last name Konno

Organization

Hirosaki University Hospital

Division name

Anesthesiology

Zip code

036-8563

Address

Aomori Prefecture, Hirosaki City, 53 Honcho

TEL

0172-33-5111

Email

mao511@hirosaki-u.ac.jp


Public contact

Name of contact person

1st name Mao
Middle name
Last name Konno

Organization

Hirosaki University Hospital

Division name

Anesthesiology

Zip code

036-8563

Address

Aomori Prefecture, Hirosaki City, 53 Honcho

TEL

0172-33-5111

Homepage URL


Email

mao511@hirosaki-u.ac.jp


Sponsor or person

Institute

Hirosaki University Hospital

Institute

Department

Personal name



Funding Source

Organization

self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Hirosaki University Hospital

Address

Aomori Prefecture, Hirosaki City, 53 Honcho

Tel

0172-33-5111

Email

mao511@hirosaki-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 03 Month 11 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 12 Month 17 Day

Date of IRB

2019 Year 12 Month 17 Day

Anticipated trial start date

2020 Year 01 Month 01 Day

Last follow-up date

2022 Year 01 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This study was a prospective observational study and participants were recruited by an open call poster between January and June 2020.


Management information

Registered date

2022 Year 03 Month 11 Day

Last modified on

2022 Year 03 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053778